医学
淋巴增殖性病變
无症状的
CD30
CD8型
病理
CD20
基因重排
回顾性队列研究
病变
淋巴瘤
胃肠病学
免疫学
抗原
生物
生物化学
基因
作者
Haoze Shi,Jing Zhang,Jingshu Xiong,Lu Gan,Yiqun Jiang,Xiu-Lian Xu,Wei Zhang,Xuesi Zeng,Jianfang Sun,Hao Chen
摘要
Abstract Background Primary cutaneous CD4‐positive small/medium pleomorphic T‐cell lymphoproliferative disorder has been defined as a type of lymphoproliferative disorder with indolent clinical course and excellent prognosis, yet a precise diagnosis is still hard to reach. Methods A retrospective analysis of 22 patients including 16 females and six males was performed. Results The age of patients ranged from 5 to 79 years. The average age of all patients was 43.5, and the median age of all patients was 44.5. Two patients had multiple lesions, and others were presented with a solitary asymptomatic lesion. Besides general features, folliculotropism was observed in four cases. In addition to express CD3 and CD4, CD30 were positive to some extent. Some reactive cells could express CD8 and CD20. For follicular helper T‐cell markers, although CXCL‐13 was negative in the stained cases (18/18), the expression of PD‐1 (12/17), BCL‐6 (12/16) and CD10 (11/15) was observed in most cases. In addition, we performed T‐cell receptor (TCR) rearrangement on five patients, and all of them showed monoclonality. Nearly all patients had excellent prognosis. Conclusions Primary cutaneous CD4‐positive small/medium pleomorphic T‐cell lymphoproliferative disorder is complex. Some features like folliculotropism should also be noted. Besides, the expression of follicular helper T‐cell markers is not invariable. Moreover, CD8 positivity, Ki‐67 index, and lesion number were perhaps not absolute prognostic indicators. To reach a diagnosis of this rare entity, putting all the pieces together is important.
科研通智能强力驱动
Strongly Powered by AbleSci AI